These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 11239541

  • 1. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 2. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 3. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G, Lambrinoudaki I, Panoulis C, Sioulas V, Rizos D, Caramalis G, Botsis D, Creatsas G.
    Maturitas; 2005 Apr 11; 50(4):321-30. PubMed ID: 15780533
    [Abstract] [Full Text] [Related]

  • 4. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect on androgens and sex hormone binding globulin.
    Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD.
    Fertil Steril; 2003 Mar 11; 79(3):534-42. PubMed ID: 12620436
    [Abstract] [Full Text] [Related]

  • 5. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M, Carlström K, Svane G, Azavedo E, Kloosterboer H, Von Schoultz B.
    Gynecol Endocrinol; 2005 Feb 11; 20(2):110-5. PubMed ID: 15823831
    [Abstract] [Full Text] [Related]

  • 6. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women.
    Stomati M, Hartmann B, Spinetti A, Mailand D, Rubino S, Albrecht A, Huber J, Petraglia F, Genazzani AR.
    J Endocrinol Invest; 1996 Sep 11; 19(8):535-41. PubMed ID: 8905477
    [Abstract] [Full Text] [Related]

  • 7. Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study.
    Winkler UH, Altkemper R, Kwee B, Helmond FA, Coelingh Bennink HJ.
    Fertil Steril; 2000 Jul 11; 74(1):10-9. PubMed ID: 10899490
    [Abstract] [Full Text] [Related]

  • 8. Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Am J Obstet Gynecol; 2000 Sep 11; 183(3):575-82. PubMed ID: 10992176
    [Abstract] [Full Text] [Related]

  • 9. Sex hormones in postmenopausal women receiving low-dose hormone therapy: the effect of BMI.
    Lambrinoudaki I, Armeni E, Rizos D, Deligeoroglou E, Kofinakos P, Kaparos G, Alexandrou A, Creatsa M, Logothetis E, Kouskouni E.
    Obesity (Silver Spring); 2011 May 11; 19(5):988-93. PubMed ID: 20948523
    [Abstract] [Full Text] [Related]

  • 10. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female.
    Ali I, James T, Meston N, Wojnarowska F, Shine B.
    Clin Chem Lab Med; 2009 May 11; 47(2):202-7. PubMed ID: 19191727
    [Abstract] [Full Text] [Related]

  • 11. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF, Andrade AT, Ribeiro LC, Castro IQ, Brandão M, Polisseni F, Guerra Mde O.
    Maturitas; 2013 Feb 11; 74(2):172-8. PubMed ID: 23201326
    [Abstract] [Full Text] [Related]

  • 12. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct 11; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 13. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH, Svenstrup B, Bennett P, Sandahl Christiansen J.
    Clin Endocrinol (Oxf); 1999 Jun 11; 50(6):791-800. PubMed ID: 10468952
    [Abstract] [Full Text] [Related]

  • 14. Effect of postmenopausal estrogen replacement on circulating androgens.
    Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC.
    Obstet Gynecol; 1997 Dec 11; 90(6):995-8. PubMed ID: 9397118
    [Abstract] [Full Text] [Related]

  • 15. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
    Campagnoli C, Colombo P, De Aloysio D, Gambacciani M, Grazioli I, Nappi C, Serra GB, Genazzani AR.
    Maturitas; 2002 Apr 25; 41(4):299-311. PubMed ID: 12034517
    [Abstract] [Full Text] [Related]

  • 16. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density.
    Lundström E, Christow A, Kersemaekers W, Svane G, Azavedo E, Söderqvist G, Mol-Arts M, Barkfeldt J, von Schoultz B.
    Am J Obstet Gynecol; 2002 Apr 25; 186(4):717-22. PubMed ID: 11967497
    [Abstract] [Full Text] [Related]

  • 17. Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens.
    Biglia N, Ambroggio S, Ponzone R, Sgro L, Ujcic E, Dato FA, Sismondi P.
    Maturitas; 2003 Aug 20; 45(4):283-91. PubMed ID: 12927315
    [Abstract] [Full Text] [Related]

  • 18. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N, Genazzani AD, Bernardi F, Casarosa E, Pieri M, Palumbo M, Picciarelli G, Gabbanini M, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2005 Mar 20; 20(3):144-9. PubMed ID: 16019353
    [Abstract] [Full Text] [Related]

  • 19. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L, Naessén T, Eriksson K, Rune C.
    Clin Endocrinol (Oxf); 1996 Jun 20; 44(6):651-8. PubMed ID: 8759177
    [Abstract] [Full Text] [Related]

  • 20. Androgen and SHBG serum concentrations in late post-menopause women.
    Skałba P, Wójtowicz M, Sikora J.
    Med Sci Monit; 2003 Mar 20; 9(3):CR152-6. PubMed ID: 12640346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.